Therefore, we aimed to establish whether colorectal cancer patients with elevated high-sensitivity cardiac troponin I (hs-cTnI) before tumor resection surgery were less likely to survive or more likely to have MACE than were patients without elevated hs-cTnI. The gene discussed is TNNI3; the disease is colorectal cancer.